HPM Partners »

Keros Therapeutics shares owned by HPM Partners

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by HPM Partners from 13F filings

Historical chart of HPM Partners investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by HPM Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by HPM Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $196k 18k 10.70

More positions owned by HPM Partners

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Microsoft Corporation (MSFT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Broadcom (AVGO)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core Us Aggbd Et (AGG)
Procter & Gamble Company (PG)
Eli Lilly & Co. (LLY)

View all positions for HPM Partners

Top funds holding Keros Therapeutics

BlackRock
Nantahala Capital Management
AQR Capital Management
Vanguard Capital Management
OrbiMed Advisors
Federated Investors
Vanguard Portfolio Management
Mackenzie Financial
Madison Avenue Partners
Qube Research & Technologies
Jacobs Levy Equity Management
State Street Corporation
Geode Capital Management
Dimensional Fund Advisors
Citadel Advisors

View all funds holding Keros Therapeutics